United Therapeutics Corp (NASDAQ:UTHR)

134.93
Delayed Data
As of Feb 16
 -1.18 / -0.87%
Today’s Change
112.01
Today|||52-Week Range
169.89
-8.80%
Year-to-Date

Today’s Trading

Previous close136.11
Today’s open136.38
Day’s range134.77 - 139.22
Volume330,541
Average volume (3 months)400,032
Market cap$5.8B
Data as of 4:00pm ET, 02/16/2018

Growth & Valuation

Earnings growth (last year)+19.89%
Earnings growth (this year)-16.45%
Earnings growth (next 5 years)-8.45%
Revenue growth (last year)+9.08%
P/E ratio11.9
Price/Sales4.20
Price/Book3.13

Competitors

 Today’s
change
Today’s
% change
RDYDr.Reddy's Laborator...+0.01+0.03%
GRFSGrifols SA-0.07-0.30%
IONSIonis Pharmaceutical...+0.27+0.54%
----
Data as of 4:02pm ET, 02/16/2018

Financials

Next reporting dateFebruary 27, 2018
EPS forecast (this quarter)$4.00
Annual revenue (last year)$1.6B
Annual profit (last year)$713.7M
Net profit margin44.64%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chairman &
Chief Executive Officer
Martine A. Rothblatt
President &
Chief Operating Officer
Michael Benkowitz
Corporate headquarters
Silver Spring, Maryland

Forecasts